Laurence Jay Korn, Director at PDL BIOPHARMA, INC. (PDLI), sold 180 shares at $31.80 ($6K) on 2006-02-28, disclosed to the SEC on 2006-03-02.
Scheduled sale ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PDLI | SELL | 2006-03-07 | $477K | — | Filing → |
| PDLI | SELL | 2006-03-03 | $789K | — | Filing → |
| PDLI | SELL | 2006-01-11 | $2.2M | — | Filing → |